Involvement of Muscle Mitochondrial Dysfunction in Frailty in Older Adults. Role of Exercise
- NCT ID
- NCT07828847
- Registry status
- Recruiting
- Study type
- Not specified in the registry data
- Phase
- Not applicable
- Sponsor
- Fundación para la Investigación del Hospital Clínico de Valencia
Overview
ClinicalTrials.gov lists this study as Recruiting.
Enrollment: 120 participants (Estimated).
What is being studied
No interventions are listed in the registry data.
Who may be eligible
- Ages
- Not specified in the registry data
- Sex
- Not specified in the registry data
- Healthy volunteers accepted
- Yes
ClinicalTrials.gov lists the following eligibility criteria.
Inclusion Criteria:
* Inclusion criteria for young controls
* Healthy young adults (18-35 years old)
* Without any pathology or treatment
* Inclusion criteria for older controls
* Healthy older adults (65 years or older)
* Not currently enrolled in a resistance training program
* Inclusion criteria for cases
* Age over 65 years
* Diagnosis of frailty or robustness
* Diagnosis of type 2 diabetes mellitus
* Glycosylated hemoglobin (HbA1c) less than 9%
* Treatment with metformin
* Not currently enrolled in a resistance training program
Exclusion Criteria:
* Exclusion criteria for young controls
* Pregnancy or suspected pregnancy
* Body mass index greater than 35 kg/m2
* Treatment within the last 30 days with oral corticosteroids
* Edema or severe fluid regulation disorders that could alter bioimpedance results
* Allergy to the local anesthetic mepivacaine
* Prostheses, metal implants, or surgical staples lodinated or barium contrast for other imaging tests within the last 7 days
* Exclusion criteria for older controls
* Decompensated and uncontrolled chronic diagnoses
* Body mass index greater than 35 kg/m2
* Treatment within the last 30 days with oral corticosteroids
* Systemic diseases, active oncological disease, liver cirrhosis, untreated hypothyroidism, or severe chronic obstructive pulmonary disease (COPD).
* Severe edema or fluid regulation disorders that could alter bioimpedance results
* Allergy to the local anesthetic mepivacaine
* Prostheses, metal implants, or surgical staples Iodinated or barium contrast for other imaging tests in the last 7 days
* Exclusion criteria for cases
* Diagnosis of pre-frailty
* Age over 80 years
* Body mass index greater than 35 kg/m2
* Time since onset of diabetes mellitus type 2 less than 10 years
* Treatment with insulin
* Treatment with allopurinol
* Treatment with anticoagulant or antiplatelet drugs
* Treatment within the last 30 days with oral corticosteroids
* Advanced chronic complications of diabetes mellitus type 2 :
Renal failure (clearance \<30 ml/min/m2) Macroalbuminuria greater than 200 mg/g Ischemic vascular diseases (acute myocardial infarction) Myocardial infarction, angina, stroke) Proliferative retinopathy or laser therapy Ulcerated diabetic foot or lower limb amputations, except for digital amputations
* Systemic diseases, active oncological disease, liver cirrhosis, untreated hypothyroidism, or severe chronic obstructive pulmonary disease
* Physical limitations in the lower limbs (acute or acute-on-chronic inflammatory processes, limited joint range of motion, chronic pain (visual analogue scale for pain \> or = 4, etc.)
* Senile dementia
* Edema or severe fluid regulation disorders that may alter bioimpedance results
* Allergy to the local anesthetic mepivacaine
* Pacemaker, metallic prostheses or implants, surgical staples, and radiopaque tubes or catheters Iodinated or barium contrast for other imaging tests within the last 7 days
Study locations
1 study location is listed.
Site recruitment status is not specified in the registry data for these locations.
Countries: Spain
Sample of listed locations
- University of Valencia/Hospital Clínico Universitario de València, — Valencia, 46010, Spain — Site recruitment status not specified in the registry data
Study details
- Start date
- January 29, 2022
- Primary completion date
- July 31, 2028
- First posted
- September 18, 2026
Source and update information
- Source
- ClinicalTrials.gov
- NCT ID
- NCT07828847
- Registry last updated
- September 18, 2026
- QualifiedStudies registry data refreshed
- September 21, 2026
View NCT07828847 on ClinicalTrials.gov
Trial information can change. Confirm current study details with the study team or the registry.
About joining clinical research
Find clinical trials you may match with
QualifiedStudies can help you search for research opportunities related to your health. Availability of this specific study through QualifiedStudies has not been established.
Find clinical trials you may match with | Diabetes (Type II) studies | Clinical trial FAQ